MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX™ inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
Company Details
- Employees
- 114
- Founded
- -
- Phone
- 650-386-3100
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- mappharma.com
Map Pharmaceuticals Questions
Map Pharmaceuticals's helpline number is 650-386-3100
Map Pharmaceuticals's website is mappharma.com
Map Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/map-pharmaceuticals
Map Pharmaceuticals has
114 employees.
View email and phone details for 114
employees at Map Pharmaceuticals.
Map Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Map Pharmaceuticals's top competitors are
Winc-Alinc | Women In Cancer-All In Cancer,
Apex Pharma,
Map Pharma,
Kardigan,
Raaha Llc,
Pfizer,
Thinknicity,
Prolaio,
Kintiga,
Mapp Biopharmaceutical Inc.
Map Pharmaceuticals's categories are Pharmaceutical Manufacturing
Map Pharmaceuticals's founding year is 2005
